Skip to main content
search

Parliamentary Debates and Questions

S5W-03150: Miles Briggs (Lothian)

Scottish Conservative and Unionist Party

Date lodged: 23 September 2016

To ask the Scottish Government what bisphosphonates are available for cancer patients.

Answered by: Shona Robison 7 October 2016

A number of bisphosphonate medicines are licensed and have been accepted for use in Scotland for the treatment of osteoporosis and also for the reduction of bone damage when cancer has already spread to the bone. At this time no bisphosphonate has a license to reduce the risk of cancer spreading to the bone.

Where a medicine does not have a license for a specific condition NHS boards in Scotland have guidance and procedures in place for off-label prescribing. A decision to recommend a drug off-label should be based on the clinical judgement of the prescriber concerned and must take account of safety and efficacy risks.